Canada - English - Health Canada

marcan pharmaceuticals inc - ondansetron (ondansetron hydrochloride) - tablet - 4mg - ondansetron (ondansetron hydrochloride) 4mg - 5-ht3 receptor antagonists

Canada - English - Health Canada

marcan pharmaceuticals inc - ondansetron (ondansetron hydrochloride) - tablet - 8mg - ondansetron (ondansetron hydrochloride) 8mg - 5-ht3 receptor antagonists

Canada - English - Health Canada

auro pharma inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists

Canada - English - Health Canada

auro pharma inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists

Canada - English - Health Canada

auro pharma inc - ondansetron (ondansetron hydrochloride dihydrate) - solution - 2mg - ondansetron (ondansetron hydrochloride dihydrate) 2mg - 5-ht3 receptor antagonists

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - ondansetron hydrochloride dihydrate 5mg equivalent to ondansetron 4 mg;   - film coated tablet - 4 mg - active: ondansetron hydrochloride dihydrate 5mg equivalent to ondansetron 4 mg   excipient: hypromellose iron oxide yellow lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water   titanium dioxide - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. also indicated for the prevention of post-operative nausea and vomiting

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - ondansetron hydrochloride dihydrate 10mg equivalent to ondansetron 8 mg;   - film coated tablet - 8 mg - active: ondansetron hydrochloride dihydrate 10mg equivalent to ondansetron 8 mg   excipient: hypromellose iron oxide yellow lactose magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water   titanium dioxide - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. also indicated for the prevention of post-operative nausea and vomiting

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.986 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; lactose; titanium dioxide; hypromellose; microcrystalline cellulose; triacetin - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.972 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; lactose; titanium dioxide; hypromellose; triacetin; iron oxide yellow - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - ondansetron -